Investors / Spain / Ysios Capital
Ysios Capital
Venture capital · Spain · Europe
Ysios Capital is a European venture capital firm that funds private biotech companies developing novel therapeutic drugs. It manages over €400M across three global funds and has offices in San Sebastian and Barcelona.
Invests inHealthcare & Biotech
In its own wordsbiotechtherapeuticslife sciencesdrug developmenthealthcare
Your fit with Ysios Capital
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsYsios Capital lists 32 checked portfolio companies on its own site and is named in 5 funding rounds. Its most frequent entry is Series B, 60% of the companies with a known first round. Its largest themes are Healthcare & Biotech (93%), Media & Entertainment (3%) and Developer Tools (3%). 32% of its companies are based in United States. It invests most often alongside Kurma Partners, HealthCap and Novartis Venture Fund.
Counts come from funding rounds that name Ysios Capital, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Ysios Capital's whole history. Rounds on record name 5 companies; its own site lists 32. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundYsios Capital does not state its stages on its site, so only what it does is shown.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 20% |
| Series B | 60% |
| Growth | 20% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 1 | 0 |
| '26 | 4 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 68th | 30 companies |
| Recent activity | 82th | 4 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 77th | 10% of companies confirmed by a round |
| Sector focus | 96th | 93% in its largest sector |
| Reach | 88th | 7 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Kurma Partners | 6 |
| HealthCap | 4 |
| Novartis Venture Fund | 4 |
| Asabys Partners | 3 |
| BioGeneration Ventures | 3 |
| Columbus Venture Partners | 3 |
| Criteria Bio Ventures | 3 |
| Jeito Capital | 3 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers3094%
- No longer answers00%
- Points to another company26%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 93% | 15% |
| Media & Entertainment | 3% | 4% |
| Developer Tools | 3% | 0% |
Co-investor network
who it backs companies with, and who they back togetherCompare Ysios Capital head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Funds
from public registers and its siteRecent portfolio activity
when companies last raised with Ysios Capital| Date | Company | Stage |
|---|---|---|
| 19 Aug 2026 | Series A | |
| 4 Jun 2026 | Series B | |
| 14 Apr 2026 | Series C+ | |
| 11 Jun 2025 | Series B |
Round details for Ysios Capital
Amounts, full round histories and every co-investor in Ysios Capital's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
32 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Adcendo is developing a new generation of antibody-drug conjugates to address cancers with high unmet medical need. | Healthcare & Biotech | Apr 2026Series C+ | Funding round | |
| Adcendo is developing a new generation of antibody-drug conjugates to address cancers with high unmet medical need. | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Amgen operates in the biotechnology industry, conducting research and development, manufacturing, and distributing various therapies and products. | Healthcare & Biotech | Portfolio page | ||
| Aura Biosciences is a clinical-stage biotechnology company that develops targeted oncology therapies for ocular cancers. | Healthcare & Biotech | Portfolio page | ||
| CorWave is a clinical-stage medical device company that develops implantable heart-assist pumps (LVADs) for patients with advanced heart failure. | Healthcare & BiotechMedia & Entertainment | Portfolio page | ||
| CVRx develops and implants a device to treat heart failure | Healthcare & Biotech | Portfolio page | ||
| Engrail Therapeutics is a clinical-stage pharmaceutical company that develops new treatments for disorders of the nervous system. | Healthcare & Biotech | Portfolio page | ||
| Fusion Pharmaceuticals develops targeted alpha therapeutics for precision medicine to treat cancers | Healthcare & Biotech | Portfolio page | ||
Healthcare & Biotech | Portfolio page | |||
| Babyscripts provides a maternity care solution that uses early risk detection to improve maternal health outcomes. | Healthcare & Biotech | Portfolio page | ||
| Inbiomotion develops a test to help select breast cancer patients for adjuvant treatment with bisphosphonates | Healthcare & Biotech | Portfolio page | ||
| KALA BIO is a biopharmaceutical company that develops therapies and utilizes data and AI technology for clinical research and enterprise applications. | Healthcare & Biotech | Portfolio page | ||
| Aug 2026Series A | Page + round | |||
| Lava Therapeutics develops therapeutics to fight cancer using gamma delta T cells | Healthcare & Biotech | Portfolio page | ||
| Memo Therapeutics develops therapeutic antibodies to treat viral infections and cancer. | Healthcare & Biotech | Portfolio page | ||
| Mineralys Therapeutics is focused on improving outcomes for people managing hypertension, CKD and related diseases driven by dysregulated aldosterone. | Healthcare & Biotech | Portfolio page | ||
| Minoryx Therapeutics discovers and develops novel treatments for severe orphan diseases of the central nervous system | Healthcare & Biotech | Portfolio page | ||
| Neurona Therapeutics develops cell therapies for targeted repair of dysfunctional neural circuits underlying chronic diseases | Healthcare & Biotech | Portfolio page | ||
| NorthSea Therapeutics develops novel therapies for rare liver diseases | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- ysioscapital.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 11 Jun 2025
- Companies checked
- 32
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Ysios Capital's profile as data
Pull Ysios Capital's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/ysioscapital.com
# also
GET /v1/firms/ysioscapital.com/portfolio
GET /v1/firms/ysioscapital.com/coinvestors
GET /v1/firms/ysioscapital.com/news